Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine

C A Pickett1, A Gutierrez-Hartmann

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.

Insights

Ras signaling is crucial for v-Src tyrosine kinase but not epidermal growth factor (EGF) effects on gene activation in pituitary cells. This highlights cell-specific differences in growth factor signaling pathways.

Area of Science:

  • Cellular and Molecular Biology
  • Signal Transduction
  • Gene Regulation

Background:

  • p21Ras is a key signaling molecule in growth factor receptor and tyrosine kinase pathways.
  • The exact role of Ras in cell-specific transcriptional responses to growth factors is not fully understood.

Purpose of the Study:

  • To investigate the role of Ras in coupling epidermal growth factor receptor (EGF-R) and v-Src tyrosine kinase signals to the activation of the rat prolactin (rPRL) gene promoter.
  • To determine if Ras is essential for EGF- or v-Src-mediated transcriptional activation in GH4 cells.

Main Methods:

  • Utilized a transient cotransfection model system in GH4 rat pituitary neuroendocrine cells.
  • Investigated the effects of epidermal growth factor (EGF), v-Src, and dominant-negative Ras (N17Ras) on the activation of the rPRL and c-Fos promoters.

Main Results:

  • EGF significantly stimulated the rPRL promoter in a dose- and time-dependent manner.
  • v-Src also activated the rPRL promoter, an effect almost completely inhibited by N17Ras.
  • EGF-stimulated c-Fos promoter activity was unaffected by N17Ras, while v-Src activation was blocked.

Conclusions:

  • Ras is not required for EGF-mediated control of the rPRL and c-Fos promoters in GH4 cells.
  • Ras is critical for mediating v-Src effects on these promoters.
  • The functional significance of EGF-R and Ras pathway interactions may differ based on cell type and signaling context.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.3K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
111.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.7K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
544